Multiple Myeloma

Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval
Reuters
Tue, 02/20/24 - 05:54 pm
JNJ
Tecvayli
FDA
Multiple Myeloma
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
GSK
Blenrep
Multiple Myeloma
clinical trials
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies
Regeneron touts possible 'best-in-class' myeloma bispecific, but adverse events climb to 100%
Fierce Biotech
Thu, 12/7/23 - 11:52 am
Regeneron
clinical trials
bispecific
Multiple Myeloma
patient deaths
linvoseltamab
GSK cancer drug Blenrep gets surprise trial win
BioPharma Dive
Tue, 11/28/23 - 10:19 am
GSK
Blenrep
clinical trials
Multiple Myeloma
Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting
BioSpace
Thu, 11/2/23 - 11:36 am
Legend Biotech
Multiple Myeloma
cilta-cel
ASH 2023
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
AbbVie’s venetoclax fails Phase III myeloma trial
Clinical Trials Arena
Mon, 10/2/23 - 10:12 am
AbbVie
venetoclax
Multiple Myeloma
clinical trials
In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
Fierce Pharma
Fri, 09/29/23 - 12:13 pm
AbbVie
Roche
Venclexta
Multiple Myeloma
J&J shines light on key role in multiple myeloma care team, vowing to raise awareness and offer support
Fierce Pharma
Tue, 09/26/23 - 10:10 am
JNJ
Multiple Myeloma
pharma marketing
AbbVie Passes on License Option for Harpoon’s TriTAC Multiple Myeloma Program
BioSpace
Thu, 09/14/23 - 10:02 am
AbbVie
Harpoon Therapeutics
HPN217
Multiple Myeloma
BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst
Fierce Biotech
Thu, 08/31/23 - 10:55 am
Bristol Myers Squibb
Revlimid
Pomalyst
Multiple Myeloma
mezigdomide
FDA approves bispecific drug from Pfizer for multiple myeloma
BioPharma Dive
Mon, 08/14/23 - 06:44 pm
Pfizer
bispecifics
Elrexfio
Multiple Myeloma
FDA
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Thu, 07/6/23 - 10:19 am
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
EHA 2023: Janssen’s talquetamab shows promise in multiple myeloma
Clinical Trials Arena
Tue, 06/13/23 - 10:39 am
talquetamab
JNJ
Multiple Myeloma
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
After FDA's delayed hold for multiple myeloma drug, Molecular Templates is back in action
Fierce Biotech
Thu, 06/1/23 - 06:38 pm
Molecular Templates
clinical trials
MT-0169
FDA
Multiple Myeloma

Pages